Carry-over in pre-dose samples for steady state BE [Study As­sess­ment]

posted by jag009  – NJ, 2019-04-02 17:46 (747 d 23:22 ago) – Posting: # 20115
Views: 2,517

Hi,

» We did a multiple dose (5 weeks, 1 TDS patch every week) bioequivalence study. The BE was assessed at week 5 at steady state. It was a 3-period study. In period 2 and 3, we observed some carry-over from the previous period treatments.

Did you achieve steady state in all three treatments?

Complete thread:

Activity
 Admin contact
21,419 posts in 4,475 threads, 1,510 registered users;
online 10 (0 registered, 10 guests [including 4 identified bots]).
Forum time: Monday 17:08 CEST (Europe/Vienna)

There is one certainty in drug development
and statistics that one can depend on:
the data are always late.    Scott Patterson and Byron Jones

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5